CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938 · cited 1×
“Engagement of CD95 does not seem to involve the recruitment of TRAF proteins (Nagata, 1997), yet in some cell types activation of NF-kB following stimulation of CD95 was reported (Malinin et al., 1997; Packham et al., 1997).”
BackgroundAn Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047 · cited 1×
“Inhibition of NF-kB sensitized cells to TNFa-mediated apoptosis (Barket and Gilmore, 1999; Beg and Baltimore, 1996).”
BackgroundTwo CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900 · cited 1×
“…decisions are regulated by the death receptors TNF-R1, CD95 (Fas, APO-1), TRAIL-R1 (DR4), TRAIL-R2 (DR5) and their cognate death ligands TNFa, CD95 ligand and TRAIL (APO-2L), respectively (Wiley et al., 1995; Pitti et al., 1996; Peter et al., 1998; Pan et al., 1997; Walczak et al., 1997).”
BackgroundWang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711 · cited 4×
“Figure 9 demonstrates that c-IAP1 and XIAP levels were transiently elevated by both, anti-CD95 and TRAIL, whereas c-IAP2 was not induced following CD95ligation and even down-regulated after TRAIL-receptor stimulation.”
BackgroundInfluentialInhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563 · cited 1×
“Several intracellular proteins may inhibit apoptosis by interfering with death receptor signal transduction either at the DISC (FLIPs) (Irmler et al., 1997; Leverkus et al., 2000) or mitochondrial (Bcl-2, Bcl-xL) level (Reed, 1998).”
BackgroundInduction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793 · cited 1×
“…decisions are regulated by the death receptors TNF-R1, CD95 (Fas, APO-1), TRAIL-R1 (DR4), TRAIL-R2 (DR5) and their cognate death ligands TNFa, CD95 ligand and TRAIL (APO-2L), respectively (Wiley et al., 1995; Pitti et al., 1996; Peter et al., 1998; Pan et al., 1997; Walczak et al., 1997).”
BackgroundThe Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767 · cited 1×
“…decisions are regulated by the death receptors TNF-R1, CD95 (Fas, APO-1), TRAIL-R1 (DR4), TRAIL-R2 (DR5) and their cognate death ligands TNFa, CD95 ligand and TRAIL (APO-2L), respectively (Wiley et al., 1995; Pitti et al., 1996; Peter et al., 1998; Pan et al., 1997; Walczak et al., 1997).”
BackgroundMAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M. P., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,280 · cited 1×
“Engagement of CD95 does not seem to involve the recruitment of TRAF proteins (Nagata, 1997), yet in some cell types activation of NF-kB following stimulation of CD95 was reported (Malinin et al., 1997; Packham et al., 1997).”
BackgroundInfluentialControl of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Cited by
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 553
Anticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 510
Arlt, A., Gehrz, A., Müerköster, S., Vorndamm, J., Kruse, M.-L., Fölsch, U. R., & Schäfer, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206390 · Cited by 474
Self-citationDiscovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology
Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., van Heek, T., Ashfaq, R., Meyer, R., Walter, K., Berg, K., Hollingsworth, M. A., Cameron, J. L., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62551-5 · Cited by 294
Pancreatic Cancer: Basic and Clinical Aspects
Schneider, G., Siveke, J. T., Eckel, F., & Schmid, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.001 · Cited by 289
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., & Toge, T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0522-7 · Cited by 253
Developing TRAIL/TRAIL death receptor-based cancer therapies
Yuan, X., Gajan, A., Chu, Q., Xiong, H., Wu, K., & Wu, G. S. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9728-y · Cited by 248
Nuclear Factor-κB Activation: A Question of Life or Death
Shishodia, S., & Aggarwal, B. B. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.028 · Cited by 236
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179
TRAIL as a target in anti-cancer therapy
Wu, G. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.029 · Cited by 168
Metadata
- Authors
- Trauzold, A., Wermann, H., Arlt, A., Schütze, S., Schäfer, H., Oestern, S., Röder, C., Ungefroren, H., Lampe, E., Heinrich, M., Walczak, H., & Kalthoff, H.
- Venue
- Oncogene
- Published
- 2001-07-12
- Volume
- 20
- Issue
- 31
- Pages
- 4258-4269
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2096165523
- Cited by
- 168
- References
- 35
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.